Dapagliflozin-13C6-1

MedChem Express

Dapagliflozin-13C6-1

5

Research Use Only

C15 13C6H25ClO6

414.83

Dapagliflozin-13C6-1 is 13C labeled Dapagliflozin. Dapagliflozin (BMS-512148), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine[1]. Dapagliflozin induces HIF1 expression and attenuates renal IR injury[2].

O[13CH2][13C@@H]1[13C@H]([13C@@H]([13C@H]([13C@@H](O1)C2=CC(CC3=CC=C(C=C3)OCC)=C(C=C2)Cl)O)O)O

12352200